Literature DB >> 12620649

Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis.

Alexandre I Danilov1, Magnus Andersson, Nasrin Bavand, N Peter Wiklund, Tomas Olsson, Lou Brundin.   

Abstract

Nitric oxide (NO) is formed as a consequence of induction of the iNOS enzyme during inflammatory disorders. To investigate NO production in multiple sclerosis (MS), we determined the concentrations of its oxidation products (NOx) in the cerebrospinal fluid (CSF) and plasma of 61 MS patients. The patients were divided into three groups on the basis of their clinical disease activity. The total levels of NOx in CSF were significantly increased in all MS groups as compared to healthy controls and tension headache patients. CSF nitrite correlated with clinical disease activity. At exacerbation, the CSF nitrite levels exceed the plasma level. This suggests that clinical disease activity is due to a CNS inflammatory response, which is more intense and qualitatively different from that during clinical stable phases. This study supports NO involvement in the pathogenesis of MS and determination of nitrite levels may be useful a surrogate marker for disease activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620649     DOI: 10.1016/s0165-5728(02)00464-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

1.  Differences in systemic and central nervous system cellular immunity relevant to relapsing-remitting multiple sclerosis.

Authors:  Makoto Matsui; Shin-ichi Araya; Hui-Yun Wang; Kouji Matsushima; Takahiko Saida
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

Review 2.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 3.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

4.  The importance of nitric oxide and arginase in the pathogenesis of acute neuroinflammation: are those contra players with the same direction?

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Radmila Pavlovic; Dusica Pavlovic
Journal:  Neurotox Res       Date:  2014-04-26       Impact factor: 3.911

Review 5.  Role of nitric oxide in cluster headache.

Authors:  Anna Steinberg; A Ingela M Nilsson Remahl
Journal:  Curr Pain Headache Rep       Date:  2012-04

6.  No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab.

Authors:  M Andersson; E Svenungsson; M Khademi; J Lampa; L Brundin; E Wallström
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

7.  Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis.

Authors:  Oscar A Bizzozero; Gisela DeJesus; Heather A Bixler; Andrzej Pastuszyn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

8.  Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.

Authors:  Ana Paula Kallaur; Edna Maria Vissoci Reiche; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Wildea Lice de Carvalho Jennings Pereira; Daniela Frizon Alfieri; Tamires Flauzino; Caio de Meleck Proença; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

9.  Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.

Authors:  Sayonara R Oliveira; Ana Paula Kallaur; Edna M V Reiche; Damacio R Kaimen-Maciel; Carolina Panis; Marcell Alysson B Lozovoy; Helena K Morimoto; Michael Maes; Isaias Dichi; Andrea Name Colado Simão
Journal:  Mol Neurobiol       Date:  2016-03-30       Impact factor: 5.590

10.  Levodopa-induced dyskinesias in Parkinson's disease increase cerebrospinal fluid nitric oxide metabolites' levels.

Authors:  Bruno L Santos-Lobato; Mariza Bortolanza; Lucas César Pinheiro; Marcelo E Batalhão; Ângela V Pimentel; Evelin Capellari-Carnio; Elaine A Del-Bel; Vitor Tumas
Journal:  J Neural Transm (Vienna)       Date:  2021-12-23       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.